Abakkus Mutual Fund is strategically allocating 30% to smallcaps within its Flexi Cap Fund, identifying mispriced opportunities despite str...

Indian equities offer rare discounts for investors. Nippon India Mutual Fund's Equity CIO, Sailesh Raj Bhan, advises accumulating world-cla...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

The Germany-based company said it already serves 260 global capability centres (GCCs) in India, counting companies such as Mercedes-Benz, H...

Indian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...

Companies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...

Indian equity markets are holding above 24,000, buoyed by improving sentiment and steady earnings, though geopolitical tensions remain a co...

A prolonged West Asia conflict poses a risk to India Inc's profitability. Crisil Ratings predicts a significant drop in operating margins d...

Emcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...

RPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company a...

India’s IT slowdown, driven by AI-driven automation and shrinking outsourcing demand, is beginning to hit real estate, mortgages, and emplo...

Digital lenders are becoming cautious about loans to small businesses like restaurants and petrol pumps. This move follows disruptions in W...

Crude oil prices have surged past the $100 mark per barrel, leading to a dramatic rise in the cost of packaging materials and creating unce...

Experts said supply chains disrupted by the conflict will take months to stabilise, and prices of active pharmaceutical ingredients (APIs)-...

U.S. pharmaceutical imports surged in March, exceeding $50 billion, as drugmakers stockpiled inventory in anticipation of potential tariffs...

The government is in discussions with the pharma and medical devices industry to create a "national stockpile" of life-saving drugs and vit...

The government is in discussions with the pharma and medical devices industry to create a "national stockpile" of life-saving drugs and vit...